Simian virus 40 (SV40) DNA replication requires the coordinated action of multiple biochemical activities intrinsic to the virus-encoded large tumor antigen (T antigen). We report the preliminary biochemical characterization of the T antigens encoded by three SV40 mutants, 5030, 5031, and 5061, each of which have altered residues within or near the ATP binding pocket. All three mutants are defective for viral DNA replication in cultured cell lines. However, while 5030 and 5031 can be complemented in vivo by providing a wild-type T antigen in trans, 5061 exhibits a strong trans-dominant-negative phenotype. In order to determine the basis for their replication defects and to explore the mechanisms of trans dominance, we purified the T antigens encoded by each of these mutants and examined their activities in vitro. The 5061 T antigen had no measurable ATPase activity and failed to hexamerize in response to ATP, and its affinity for the SV40 origin of DNA replication (ori) DNA was not increased by ATP. In contrast, the 5030 and 5031 T antigens exhibited at least some ATPase activity and both readily formed hexamers in the presence of ATP. These mutants differed in that 5030 was very defective in an ori-dependent unwinding assay while 5031 retained significant activity. Both the 5030 and 5031 T antigens bound to ori-containing DNA, but the binding was less efficient than that of wild-type T antigen and was not affected by the presence of ATP. These results suggest that 5030 and 5031 are defective in some aspect of communication between the ATP binding and DNA binding domains and that the ability of ATP to induce T-antigen hexamerization is distinct from its action to increase the affinity for ori. Finally, all three mutants were defective for the ability to support SV40 DNA replication in vitro. Both the 5031 and 5061 T antigens inhibited wild-type-T-antigen-stimulated replication in vitro, while the 5030 T antigen did not. The fact that the 5031 T antigen was trans dominant in the in vitro assays but not in vivo indicates that the in vitro system does not accurately reflect events occurring in vivo.
The large T antigen (T antigen) encoded by simian virus 40 (SV40) plays a central role in orchestrating many aspects of viral productive infection, including DNA replication, transcriptional regulation, and virion assembly. SV40 DNA replication requires the coordinated action of several activities intrinsic to the virus-encoded large T antigen. Following infection, T antigen acts to alter host gene expression and growth control by targeting cellular transcription factors and components of the cell cycle regulatory apparatus. It is thought that some of these changes are necessary to prepare the cell for viral DNA replication. Subsequently, T antigen directs the assembly of the replication complex and the initiation of viral DNA replication at the viral origin of replication (ori).
The initiation of replication requires that T antigen bind to specific sequences within the core ori, where it subsequently assembles as a double hexamer and consequently induces the partial melting of ori DNA (4-6, 25, 34, 43) . While bound to ori, T antigen associates with components of the cellular replication apparatus, such as DNA polymerase ␣ and replication protein A, resulting in the formation of the initiation complex (14-17, 38, 41) . During the elongation steps of replication, each T-antigen hexamer moves, with each of the two replication forks functioning as a DNA helicase (59) .
T antigen is a 708-amino-acid multifunctional protein that possesses several biochemical activities, some of which map to discrete domains that can act independently of the rest of the polypeptide (18, 45) . For example, the binding of T antigen to specific sequences within the viral origin of DNA replication is mediated through its DNA binding domain (amino acids 135 to 249), while residues 371 to 625 are sufficient for ATP binding and hydrolysis (1, 9, 10, 18, 52) . In some cases, proper T-antigen function requires the coordinated action of multiple domains. For example, T-antigen DNA helicase activity requires the action of both the DNA binding and ATPase domains (60) . Some aspects of T-antigen function are regulated by phosphorylation. For example, phosphorylation of T(124) is necessary for cooperativity between the two T-antigen hexamers on ori, and thus for the ori-specific unwinding reaction, while phosphorylation of S(120) or S(123) is inhibitory for hexamer cooperativity and ori unwinding (8, 22, 37, 39, 46, 48, 55) . Furthermore, phosphorylation of S(677), which resides in the carboxy-terminal host range domain, influences the phosphorylation state of S(112), S(120), and S(123) in the amino-terminal domain, and mutation of this residue renders T antigen defective for binding to T-antigen binding site I without affecting binding to site II (48) .
T-antigen action is also regulated by its interaction with ATP. Binding of ATP to T antigen has several important consequences. First, ATP binding results in an increased affinity of T antigen for site II (4, 12) . Second, ATP binding is required for T-antigen hexamerization and thus for the assembly of a dodecamer at the ori (11, 34, 42) . Neither of these effects requires ATP hydrolysis. Third, ATP hydrolysis is required for the DNA helicase activity of T antigen.
To understand better the role of individual T-antigen activities in viral DNA replication, many SV40 T-antigen mutants that are replication defective in vivo have been characterized (9, 10, 31-33, 40, 47, 58) . In the majority of cases, the replication defects of these mutants can be complemented by supplying a wild-type T antigen in trans. However, some of the mutant T antigens cannot be complemented and exhibit a trans-dominant-negative effect on the replication activity of wild-type T antigen (3, 19) . The biochemical basis for this trans dominance is not known.
As part of our strategy to understand T-antigen function, we have generated a collection of mutants that carry deletions, insertions, or substitutions of amino acids in selected regions of the protein. In this study, we compare the biochemical properties of three mutant T antigens that have alterations near or within the nucleotide binding fold. Mutants 5030 (P417S), 5031 (D402N, V404M, V413M), and 5061 (G431ALE) are all defective for viral DNA replication in vivo. However, while the 5030 and 5031 mutants can be complemented in trans by wildtype T antigen in vivo, the 5061 mutant is strongly trans dominant negative, inhibiting wild-type replication 50-fold. We find that the non-trans-dominant mutants, 5030 and 5031, and the trans-dominant mutant, 5061, display specific responses to ATP. It is not clear whether this relates to the mechanism of trans dominance.
MATERIALS AND METHODS

Baculovirus vectors expressing mutant T antigens.
Plasmids carrying the complete viral genomes of SV40 T-antigen mutants 5030 and 5031 are described elsewhere (44a) . Mutant 5030 carries a single amino acid substitution (P417S), while 5031 has three amino acid replacements (D402N, V404M, and V413M). The 5061 mutation results in the replacement of G(431) with three amino acids (A L E) and has been described previously (19) .
Wild-type baculovirus (AcNPV), a recombinant baculovirus that expresses the wild-type T antigen (AcNPV941T), and a baculovirus transfer plasmid containing the wild-type T-antigen gene (pVL941T) were kindly provided by Robert Lanford (Southwest Foundation for Biomedical Research) and have been described previously (27) . Baculovirus transfer plasmids expressing the mutant T antigens were generated by exchanging a 1,354-bp DNA fragment (SV40 nucleotides 4558 to 3204), resulting from the digestion of pVL941T with PflMI and PstI, with the corresponding fragment from the mutant.
The Spodoptera frugiperda cell line (Sf9) was provided by Max Summers and was maintained as recommended (53) . To generate recombinant baculoviruses that express each mutant T antigen, 2.5 ϫ 10 6 Sf9 cells were washed in serumfree Grace's medium (ExCell 400; JRH Biosciences) and seeded in 25-cm 2 tissue culture flasks. The cells were incubated at 27°C for 1 h before transfection. Wild-type baculovirus (AcNPV) DNA along with the transfer vector containing the mutant T-antigen gene was mixed in a ratio of 1:4 with Lipofectin reagent (Bethesda Research Laboratories) in ExCell 400 medium, and the transfection procedure recommended by the manufacturer was followed. After transfection, 5 ml of Grace's medium plus (per liter) 3.3 g of lactalbumin hydrolysate and 3.3 g of Yeastolate (Difco) supplemented with 10% fetal bovine serum was added to the flasks and the flasks were incubated at 27°C for 5 to 7 days. The desired recombinant viruses were identified by Southern blot hybridization with SV40 DNA as a probe and purified by limiting dilution. High-titer virus stocks were then prepared and stored at 4°C.
Purification of wild-type and mutant T antigens. T antigens were purified from baculovirus-infected Sf9 cells by immunoaffinity chromatography essentially as previously described (13, 27, 49) . Routinely, 4 ϫ 10 8 Sf9 cells were infected with the appropriate recombinant baculovirus and incubated at 27°C. At approximately 43 h postinfection, the infected cells were scraped into 50-ml conical tubes, rinsed thrice with ice-cold phosphate-buffered saline-EDTA, and placed in 20 ml of lysis buffer (20 mM Tris [pH 8.0], 0.2 M LiCl, 1 mM EDTA, 0.5% Nonidet P-40 , and 1 mM dithiothreitol [DTT] plus a cocktail of protease inhibitors). The protease inhibitor cocktail included leupeptin (2 g/ml), pepstatin (0.7 g/ml), trans-epoxysuccinyl-L-leucylamido-(4-guanidino) butane (5 g/ml), Pefabloc (500 M), aprotinin (2 g/ml), soybean trypsin inhibitor (10 g/ml), and tosyl-L-phenylalanine chloromethyl ketone (10 g/ml). Incubation in lysis buffer was for 25 min on ice. Following lysis, the cellular debris was removed by centrifugation in a Sorvall RC2B at 15,000 rpm for 30 min. The supernatant was then immediately used for immunoaffinity chromatography.
The T-antigen-specific monoclonal antibody PAb416 was routinely used for immunoaffinity chromatography (24) . For some preparations, we used PAb419, PAb101, or KT3 (23, 24, 57) . All of these antibodies resulted in T-antigen preparations of equivalent yield and quality. Antibodies were purified from hybridoma supernatants or from mouse ascites fluid and then coupled to protein A-Sepharose (Pharmacia) or Affigel-10 (Bio-Rad). Infected cell lysate was pumped over a 1.4-by-0.7-cm column containing the conjugated antibody at a flow rate of 6 to 7 ml/h. The column was then washed with 25 ml of a solution containing 20 mM Tris (pH 8.0), 0.5 M NaCl, 1 mM EDTA, 10% glycerol, 1.0% NP-40, and 1 mM DTT plus the protease inhibitor cocktail described above. Next, the column was washed with 25 ml of a solution containing 20 mM Tris (pH 8.0), 0.5 M NaCl, 1 mM EDTA, 10% glycerol, and 1 mM DTT plus the protease inhibitor cocktail. The final wash was with a solution containing 20 mM Tris-HCl (pH 9.0), 0.5 M NaCl, 1 mM EDTA, 10% glycerol, and 1 mM DTT plus the protease inhibitor cocktail. All washes were done at a flow rate of 40 ml/h. T antigen was eluted from the column with 10 ml of a solution containing 20 mM 3-[cyclohexylamino]-1-propanesulfonic acid (CAPS) (pH 11.0), 0.5 M NaCl, 1 mM EDTA, 10% glycerol, and 1 mM DTT plus the protease inhibitor cocktail at a flow rate of 80 ml/h. The eluate was collected in tubes containing 0.25 volumes of a solution of 0.5 M Tris-HCl (pH 7.0), 10% glycerol, 1 mM EDTA, and 1 mM DTT plus the cocktail of protease inhibitors. The T antigen was then dialyzed overnight against a solution containing 10 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1.0 mM EDTA, 1 mM DTT, and 50% glycerol and stored at Ϫ20°C.
In preliminary experiments we noted a disturbing variability in the activity exhibited by different preparations of wild-type and mutant T antigens. We found that the single most important parameter governing this variability was the pH of the elution buffer. This problem was corrected by switching to a CAPS buffer for elution.
ATPase assays. For determination of ATPase activity, 1 g of T antigen was incubated in a reaction buffer containing 25 mM HEPES (pH 7.0), 5 mM MgCl 2 , 0.1 mM EDTA, 0.05% NP-40, 1 mM DTT, and 10 M ATP in a final reaction volume of 40 l. To each reaction tube was added 10 Ci of [␣-
32 P]ATP (ICN Pharmaceuticals, Inc.; specific activity Ͼ 600 Ci/mM). The reactions were prepared on ice and initiated with the addition of T antigen. At different time intervals, 2-l aliquots were removed, and the reaction was terminated by pipetting in 4 l of 0.75 M KH 2 PO 4 , pH 3.5. Two-microliter aliquots were spotted on polyethyleneimine (PEI)-cellulose plates (Brinkmann Instruments Inc.), which were then air dried and developed in 0.75 M KH 2 PO 4 , pH 3.5. The plates were then dried, and ATP hydrolysis was quantitated with a radioanalytic imager (Scanalytics). Stimulation of ATPase by single-stranded DNA was carried out in the presence of poly(dT) (Pharmacia) (average length, 174 bases) added to a final concentration of 20 ng/l with ATP at 50 M. ori-specific DNA binding. The ability of the mutant T antigens to recognize and bind SV40 T-antigen binding sites I and II was initially assessed by the method of McKay (36) . Digestion of pDV.XH (55) , which contains binding site II, with ApaLI and DraIII yields four DNA fragments (1, 246, 732, 561 , and 474 bp). Site II (SV40 nucleotides 5211 to 32) is contained within the 561-bp fragment. Digestion of pTBS1 (30) with SalI and HincII yields two fragments, 1,536 and 493 bp, with the larger fragment containing binding site I. Following digestion with the above enzymes the DNA fragments were end labelled with the Klenow DNA polymerase and [␣-32 P]dCTP. The labelled DNA fragments were then incubated with various amounts of T antigen, and the resulting T antigen-DNA complexes were precipitated by incubation at 4°C with PAb416 for 35 min, followed by immunoadsorption on Pansorbin (protein A-positive Staphylococcus aureus cells; Boehringer Mannheim) for 15 min. The immunoprecipitates were then rinsed three times with a solution containing 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 0.5% NP-40, resuspended in sample buffer (10 mM Tris-HCl [pH 7.5], 7.5 mM EDTA, 0.5% sodium dodecyl sulfate [SDS], 10% glycerol, 0.025% bromophenol blue), and heated for 2 min at 65°C. The samples were electrophoresed through a 1.5% agarose gel and visualized by autoradiography.
The DNA binding reactions were carried out under two different conditions. In one set of experiments, the T antigen and DNA were incubated on ice for 1 h in a reaction buffer consisting of 10 mM HEPES (pH 7.3), 0.1 mM EDTA, 0.05% NP-40, 1.0 mg of bovine serum albumin (BSA)/ml, 2.0 mM DTT, and 10 mM NaCl. In a second set of experiments, the binding reaction was carried out in 30 mM HEPES (pH 7.4), 7 mM MgCl 2 , 40 mM phosphocreatine, 1 mg of BSA/ml, and 1 mM DTT, either in the presence or absence of 1 mM adenylyl-imidodiphosphate (AMP-PNP). These latter binding experiments were carried out both at 37°C and on ice.
KMnO 4 reactivity. The protocol followed was that of Parsons et al. (42) . T antigen was incubated at 37°C for 30 min in a solution of 30 mM HEPES (pH 7.5), 7 mM MgCl 2 , 1 mM DTT, 0.1 mg of BSA/ml, 40 mM phosphocreatine, 20 g of creatine phosphokinase/ml, and 4 mM ATP. Each reaction mixture contained 500 ng of pDV.XH. After incubation, KMnO 4 was added to a final concentration of 30 mM and samples were incubated for 4 min at 37°C. Reactions were stopped with ␤-mercaptoethanol to a final concentration of 1.2 M. The samples were then adjusted to 0.3% SDS and 20 mM EDTA, pH 8.0, in a final volume of 80 l. Then 1 l of proteinase K (0.5 g/l) was added, and reaction mixtures were incubated for 45 min at 37°C. Samples were phenol extracted, and the aqueous phase of the reaction mixture was loaded onto a homemade 3-ml spin column of 1 ml of packed Sephadex G-50 fines (Pharmacia) that had been equilibrated with H 2 O at room temperature for 3 min. Samples were spun in a Sorval RT6000B refrigerated centrifuge at 4°C for 5 min at 2,000 rpm. The eluate was brought to 70 l with H 2 O, split into two 35-l fractions, and frozen at Ϫ20°C for primer extension.
For primer extension, M13 (Ϫ20) primer (Stratagene) was end-labelled with [␥-
32 P]ATP (NEN) and T4 polynucleotide kinase (Gibco BRL) and purified on a Bio Gel P-6 spin column (Bio-Rad). Four microliters of 50 mM NaOH and approximately 1 ng (2.5 ϫ 10 5 to 5.0 ϫ 10 5 cpm) of primer was added to 35 l of DNA. The mixture was heated at 80°C for 2 min and then cooled on ice. Then 10ϫ PEB (500 mM Tris-HCl [pH 7.2], 100 mM MgSO 4 , and 2 mM DTT) was added, and samples were heated at 65°C for 2 min. The samples were allowed to cool slowly to Ͻ35°C (approximately 40 min) to allow the primer to anneal. All four deoxynucleoside triphosphates were added to a final concentration of 500 M each, and reactions were incubated at 55°C for 1 min. One unit of the Klenow fragment of DNA polymerase I (Gibco BRL) was added, and reaction mixtures were incubated at 55°C for 10 min. Reactions were terminated by addition of 26 l of NE (4 M ammonium acetate and 20 mM EDTA [pH 8.0]) and 8 g of tRNA (Sigma). Samples were precipitated by the addition of 3 volumes of ethanol and kept in a dry ice-ethanol bath for 45 min. Samples were centrifuged, and pellets were washed with 70% ethanol. Samples were returned to the dry ice-ethanol bath for 5 min and then centrifuged for 15 min. Pellets were dried and resuspended in 8 l of stop solution (Sequenase kit; U.S. Biochemicals [USB]) and stored at Ϫ20°C. The reactions were sequenced with [␣- 35 S]dATP (NEN) and M13 (Ϫ20) primer by following the manufacturer's instructions in the USB Sequenase kit. The reaction products were electrophoresed for 2 to 2.5 h at 52°C on 6% sequencing gels (prepared with National Diagnostics reagents). Gels were fixed in 5% methanol and 5% acetic acid for 20 min and were then dried and exposed to Hyperfilm MP (Amersham).
DNA helicase and ori-specific unwinding assays. The nonspecific DNA helicase activity of T antigen was examined as described by Stahl et al. (51) . The substrate was prepared by annealing 0.6 g of M13 mp18(ϩ) DNA to 10 ng of the sequencing primer, (USB). The annealed fragment was radiolabelled by carrying out an extension reaction with the Klenow fragment and [␣-
32 P]dATP and purified and concentrated with a Centricon 100 (Amicon). The strand displacement reaction was carried out in 25 mM Tris-HCl (pH 7.5), 5 mM MgCl 2 , 1 mM DTT, 0.3 fmol of annealed substrate, 40 mM phosphocreatine, 0.5 g of creatine phosphokinase, 0.5 g of poly(dI-dC), 2 mM ATP, and 1 g of BSA in a reaction volume of 20 l. The reaction was initiated by the addition of T antigen, and the reaction mixture was incubated at 37°C for 1 h. Reactions were stopped by the addition of an equal volume of 1.5% SDS and 0.2 M EDTA, and the products were electrophoresed through a 12% acrylamide gel.
The ori-specific unwinding activity of T antigen was assayed essentially as described by Goetz et al. (21) . The substrate was prepared by first digesting pUC.HSO, which contains the SV40 bp 128 to 5171, including ori (30), with HindIII and radiolabelling the products by incubation with [␣- 32 P]dCTP and the Klenow enzyme. This was followed by digestion with HinfI and BamHI and by treatment with the Klenow enzyme and unlabelled deoxynucleoside triphosphates to blunt the ends. This procedure generates two labelled fragments, one of which contains the SV40 ori.
The unwinding reaction was carried out with 0.3 fmol of the substrate in 30 mM HEPES (pH 7.5), 7 mM MgCl 2 , 4 mM ATP, 40 mM phosphocreatine, 1.0 g of creatine phosphokinase, 25 mM sodium phosphate (pH 7.5), 80 ng of Escherichia coli single-stranded DNA binding protein (USB), and T antigen in a final reaction volume of 10 l. The reaction mixtures were incubated at 37°C for 1 h, and the products were electrophoresed through an 8% polyacrylamide gel.
Native gel electrophoresis. Seven micrograms of purified T antigen was incubated in a reaction buffer containing 30 mM HEPES (pH 7.4), 7 mM MgCl 2 , 40 mM phosphocreatine, 1 g of creatine phosphokinase/ml, and 1 mM DTT in a final volume of 100 l. Reaction mixtures were incubated either at 37 or 4°C in the presence or absence of 4 mM ATP. After incubation for 20 min, 20 l of sample buffer containing 75 mM Tris (pH 6.8), 50% glycerol, and 0.25% bromophenol blue was added to the reaction mixtures. When samples were crosslinked, the reactions were allowed to proceed for a further 5 min with electron microscopy-grade glutaraldehye (Polysciences Inc.) added to a final concentration of 0.04% prior to the addition of the sample buffer. Untreated T-antigen samples were adjusted to 100 l in a solution of 10 mM Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, and 1 mM DTT. Entire reaction mixtures were loaded on a native discontinuous pH gradient gel. The running gel was a 1.5-mm-thick 4 to 22% gradient acrylamide gel (16 by 20 cm) containing acrylamide and N,NЈ-diallyltartardiamide in a ratio of 28:1 in 0.375 M Tris, pH 8.8. The stacking gel was a 3% acrylamide gel in 0.125 M Tris, pH 6.8. The reaction mixture was electrophoresed at 35 mA for 12 to 14 h in running buffer containing 25 mM Tris and 192 mM glycine-HCl. Gels were silver stained with the Silver Stain Plus kit from Bio-Rad.
ori-specific DNA band shift. DNA mobility shift assays were carried out following the methods of Virshup et al. (55) . A 67-bp DNA fragment containing SV40 T-antigen binding site II was purified by agarose gel electrophoresis following digestion of pDV.XH with SnaBI and ApaLI. This fragment was end labelled with [␣-
32 P]dCTP (3,000 Ci/mmol) by using the Klenow fragment. The labelled fragment (3 fmol) was mixed with T antigen in a solution of 30 mM HEPES (pH 7.8), 7 mM MgCl 2 , 1 mM DTT, 40 mM phosphocreatine, and 4 mM AMP-PNP (Boehringer Mannheim) and incubated at 37°C for 30 min in a volume of 10 l. The protein-DNA complexes were cross-linked by treatment with 2 l of 3% glutaraldehyde (final concentration of 0.5%) for 5 min at 37°C. The products were electrophoresed on a 4% Metaphor XR agarose gel (FMC), dried onto Whatman DE81 paper, and visualized by autoradiography.
In vitro DNA replication. The ability of mutant T antigens to support SV40 DNA replication in vitro was assessed by the method of Li and Kelly (28, 29 32 P]dCTP [3,000 Ci/mM]; 40 mM phosphocreatine; 100 ng of creatine phosphokinase/l; 100 ng of template DNA; 15 l of HeLa cell extract) and 0.1 to 1.0 g of T antigen. Reaction mixtures were incubated at 37°C for various times, and the reactions were terminated by the addition of 100 l of stop solution (10 mM Tris [pH 8.0], 0.5% SDS, 5 mM EDTA, 300 g of tRNA/ml, and 1 mg of proteinase K/ml). A portion of each reaction was then removed, the DNA was precipitated with trichloroacetic acid, and radioactive incorporation was assessed by counting in a liquid scintillation counter. The remainder of each reaction mixture was incubated at 37°C for 1 h, and the DNA was then recovered by ethanol precipitation and analyzed by agarose gel electrophoresis.
RESULTS
Purification of 5030, 5031, and 5061 mutant T antigens.
Baculovirus expression vectors were used to express the wildtype T antigen and the three mutant T antigens in Sf9 cells. The T antigens were isolated from infected cell lysates by immunoaffinity chromatography. In general, the T-antigen-specific monoclonal antibody PAb416 was used as the antibody on the immunoaffinity columns, and T antigen was eluted from the column by brief exposure to pH 11.0. Figure 1 shows an example of the purity and integrity of typical T-antigen preparations used in the experiments described below. In the case of wild-type T antigen, this protocol resulted in a yield of 0.8 to 1.2 mg of purified T antigen per 4 ϫ 10 8 infected Sf9 cells. Multiple (Ͼ6) independent preparations of wild-type T antigen and each mutant T antigen were examined by the various assays described below. In some cases T antigen was eluted from the affinity column by treatment with ethylene glycol rather than by high pH. These two methods produced equally active proteins, although the yields were somewhat lower when ethylene glycol was used. The experiments described below were all performed with T antigen obtained by high-pH elution.
In vitro DNA replication. We utilized the system of Li and Kelly (28) to examine the ability of each mutant to carry out T-antigen-dependent replication of SV40 ori-containing DNA ATPase activity. We next assessed the ability of each mutant T antigen to hydrolyze ATP at 37°C. As shown in Fig. 3A , the 5061-encoded T antigen was completely defective for ATPase activity. Even when larger amounts (2.5 g) of this mutant protein were tested, no ATP hydrolysis over background was observed (data not shown). The T antigens encoded by the 5030 and 5031 mutants were able to hydrolyze ATP, although less efficiently than the wild type. Mutant 5031 showed about 30% as much activity as the wild type, while mutant 5030 had about 5 to 10% as much activity.
The low ATPase activity seen with these mutant proteins could be due to their inability to bind to ATP or the inefficient hydrolysis of ATP once it is bound. In the case of the 5031 mutant we addressed this issue by carrying out reactions at different substrate concentrations. In the experiment shown in Fig. 3B , we determined the K m of wild-type T antigen for ATP as 67 M and the V max as 3,000 pmol/h. These measurements were performed multiple times, with different preparations of wild-type T antigen giving K m values ranging from 60 to 68 M and V max values ranging from 3,000 to 2,800 pmol/h. Figure 3C shows the results when the 5031-encoded T antigen was examined. This mutant protein had a K m of 89 M (range, 70 to 110 M in multiple assays) and a V max of 1,600 pmol/h (range, 1,400 to 1,800 pmol/h in multiple assays). These results indicate that the 5031 T antigen binds ATP about as well as the wild type does but is inefficient at carrying out the hydrolysis reaction.
The ATPase activity of wild-type T antigen is stimulated four-to fivefold in the presence of single-stranded DNA (20) . We tested the effect of poly(dT) on the ATPase activity of each mutant protein (Fig. 3D) . No significant elevation of ATPase activity by poly(dT) was seen with any of the mutant proteins.
Oligomerization and ATP-induced hexamerization.
Wildtype T antigen purified from SV40-infected monkey cells or baculovirus-infected Sf9 cells appears as a mixture of oligomers that can be visualized on nondenaturing gradient polyacrylamide gels. In the presence of high concentrations of ATP, most of the T antigen is converted to hexamers and dodecamers (43) . Presumably this reflects the fact that T antigen forms double hexamers on ori and that proper assembly of dodecamers is required to initiate viral DNA replication. Figure 4 shows the results of experiments designed to assess the oligomeric state of the purified mutant T antigens and their ability to hexamerize in response to ATP. Figure 4A shows the results when wild-type and mutant T antigens were analyzed by native gel electrophoresis following their purification without any treatment. All three mutant T antigens exhibited an array of oligomers that was indistinguishable from that of the wild type.
Next we incubated the T antigens at 4 or 37°C, either in the presence or absence of ATP. Some of these reactions were then analyzed on native gels without further treatment. In other reactions, the protein complexes were cross-linked by treatment with glutaraldehyde prior to electrophoresis through native gels. ATP-induced hexamerization of wild-type T antigen was readily detectable in assays performed at 37°C and involving treatment with cross-linker. Hexamerization was much less efficient at 4°C. In reactions that were not crosslinked, hexamerization of wild-type T antigen was still observed at 37°C; however, the amount of hexamer was much less than that seen with the cross-linked samples.
Mutant 5061 was defective for ATP-induced hexamerization under all conditions tested (Fig. 4E) . On the other hand, both mutants 5030 (Fig. 4C) and 5031 (Fig. 4D ) readily formed hexamers in response to ATP. In fact, both mutants appeared to be more efficient at ATP-induced hexamerization than the wild type. This is most clearly seen in the reactions that were not cross-linked.
Binding of T antigens to SV40 DNA. SV40 T antigen binds specifically to the consensus sequence 5Ј-GAGGC-3Ј through a DNA binding domain located between amino acids 135 and 249. Several such consensus sequences are located at multiple sites within the viral regulatory region. Most notable are Tantigen binding site I, which consists of two binding sites in tandem, and site II, which contains four binding sites. T-antigen binding to site I mediates the down regulation of viral early-region transcription. Site II lies within the minimal origin of DNA replication, and T-antigen interaction here is required for the initiation of viral DNA synthesis.
First, we used an immunoprecipitation assay to assess the ability of each purified mutant T antigen to bind specifically to the site I and site II viral DNA (35) . When the binding reactions were carried out at 4°C in low-salt conditions and in the absence of magnesium and ATP, all three mutant T antigens bound specifically to site I and site II DNA (Fig. 5A and C) . The 5061 and 5031 T antigens bound both site I and site II nearly as well as the wild type did under these assay conditions, while the 5030 T antigen was much less efficient (ϳ10%). We also tested T-antigen binding to site I (Fig. 5B) and to site II (Fig. 5D ) under conditions used for in vitro DNA replication assays, that is, at 37°C in the presence of magnesium and AMP-PNP. Under these conditions binding by 5031 was significantly reduced (ϳ10%). When we tested binding by the mutant T antigens in replication buffer at 4°C, 5031 bound site II as well as the wild type did (Fig. 5E) . Thus, the ability of the 5031 T antigen to efficiently bind to site II is temperature sensitive.
We next examined the influence of ATP on T-antigen bind-
In vitro replication of SV40 DNA. The ability of each mutant T antigen to stimulate SV40 DNA replication in vitro was assessed by the system of Li et al. (30) . Various amounts (in micrograms) of T antigen were incubated with pUC.HSO DNA, which contains a functional SV40 ori, in replication buffer supplemented with HeLa cell extract at 37°C for 1 h. At various times during the incubation period, aliquots were removed from each reaction mixture and the incorporation of labelled nucleotides into DNA was assessed by precipitation with 10% trichloroacetic acid and scintillation counting. The remainder of each reaction mixture was run on a 1% agarose gel and analyzed by autoradiography. TAg, T antigen; WT, wild type; MW, molecular weight. (Fig. 5F ). The ability of 5030, 5031, or 5061 T antigen to bind site II was not significantly affected by ATP. Thus, while all three mutants retained the intrinsic ability to specifically bind to site II DNA, they were found to be defective for the ATP-induced stimulation of binding efficiency characteristic of wild-type T antigen when assayed at 37°C. We also examined the influence of ATP binding at 4°C (data not shown). Again, site II binding by the 5030 and 5061 T antigens was not affected by the presence of ATP. However, binding to site II by the 5031 T antigen was stimulated two-to threefold by ATP. Thus, the ability of ATP to stimulate site II binding by the 5031 T antigen is temperature sensitive. Assembly on ori. We next tested the ability of these T antigens to assemble into hexamers and dodecamers on ori-containing DNA. The purified T antigens were incubated at 37°C with a 67-bp DNA fragment containing the minimal SV40 origin in replication buffer containing 1 mM AMP-PNP. The protein-DNA complexes were then cross-linked with glutaraldehyde prior to electrophoresis. Figure 6 shows the results of band shift experiments with a gel system that distinguishes ori-containing fragments bound by a single hexamer from those bound by dodecamers (55) .
Reactions containing wild-type T antigen exhibited two shifted DNA fragments corresponding to a hexamer bound to ori and a dodecamer bound to ori, with dodecamer-containing DNA predominating by a ratio of approximately 3:1. Mutant 5031 behaved similarly to the wild type in this assay. Mutant 5030 also assembled into hexamers and dodecamers on the ori-containing fragment; however, it was less efficient than the wild type at the concentrations tested and less dodecamerbound DNA was seen (dodecamer/hexamer ratio, 1:2). No hexamer-or double hexamer-containing DNA fragments were formed in the presence of the 5061 T antigen. Rather, a broad smear of fragments was seen. These results suggest that 5061 can bind to ori DNA but fails to assemble into hexamers and dodecamers.
We also assessed the ability of each mutant T antigen to protect ori DNA from DNase I digestion both in the presence and absence of ATP (data not shown). In the absence of ATP, wild-type T antigen and all three mutant T antigens protected the 64-bp core ori. In the case of wild-type T antigen, the presence of ATP resulted in an expansion of the protected region due to the assembly of T-antigen double hexamers on ori (43) . Similar results were obtained with 5030 and 5031, although higher levels of T antigen were required to obtain the same degree of protection provided by the wild type. ATP had little or no effect on the footprint obtained with 5061, consistent with its inability to undergo ATP-induced hexamerization (data not shown). Distortion of ori DNA. The formation of a double hexamer of T antigen on ori leads to localized distortions of DNA structure that can be detected by measuring reactivity to KMnO 4 (42, 43) . The results shown in Fig. 7 indicated that 5031 induced these structural distortions about as efficiently as the wild type, except at position 5217, where 5031 showed about 50% of the efficiency of the wild type. Mutant 5030 was much reduced in its ability to distort ori DNA. As expected, the 5061 T antigen showed no measurable activity in this assay.
DNA helicase and ori-specific unwinding. The DNA helicase activity of each T antigen was assessed by examining its ability to catalyze the displacement of a 26-nucleotide DNA fragment annealed to closed circular single-stranded bacteriophage M13 DNA. All assays were done at 37°C. The results of representative assays are shown in Fig. 8 .
Consistent with the fact that it is defective for ATP hydrolysis, mutant 5061 failed to exhibit any measurable helicase activity. Both the 5030 and 5031 T antigens possessed significant levels of helicase activity. The 5031 T antigen was approximately 40% as active as the wild type, while the 5030 T antigen had 25% of the wild-type level of activity. Thus, despite its relatively modest ATPase activity, the 5030 T antigen serves as a reasonably efficient helicase.
Each mutant T antigen was also tested for the ability to specifically unwind DNA containing the viral ori. The results are shown in Fig. 9 . As expected, the 5061 T antigen exhibited no activity in this assay. On the other hand the 5031 T antigen   FIG. 4 . ATP-induced hexamer formation. T-antigen oligomers were resolved by electrophoresis of 7 g of purified T antigen through 4 to 22% gradient gels at 4°C under nondenaturing conditions and were visualized by silver staining. (A) Purified T antigens diluted and analyzed without any additional treatment. (B to E) Wild-type (WT) or mutant T antigens (7 g) were incubated at 37 or 4°C in replication buffer either in the presence (ϩ) or absence (Ϫ) of 4 mM ATP. Some reactions were cross-linked by treatment with gluteraldehyde (glut) prior to electrophoresis, while others were analyzed directly. The numbers to the left of each gel represent the number of monomer subunits in each oligomer.
was about 25% as active as the wild type. The 5030 T antigen, which exhibited significant helicase activity, had no detectable ori-specific unwinding activity.
trans-Dominant inhibition of DNA replication in vitro. All three mutants are defective for viral DNA replication in vivo. However, the 5030 and 5031 mutant T antigens do not significantly interfere with replication driven by the wild type when both are present in the same cell. In fact, both 5030 and 5031 are readily complemented in trans by wild-type T antigen (44a). On the other hand, the 5061 T antigen is strongly trans dominant negative in vivo, inhibiting the replication activity of wild-type T antigen by about 100-fold (19) . Therefore, we examined the influence of each mutant on the ability of wildtype T antigen to stimulate SV40 replication in vitro. Figure 10 shows the results of in vitro replication assays which contained various ratios of wild-type and mutant T antigens. The presence of 5030 T antigen had little or no effect on the ability of the wild type to stimulate replication. In contrast, both the 5031 and 5061 T antigens inhibited wild-type-stimulated replication. At equimolar ratios of the mutant and wildtype T antigens, replication was reduced to approximately 40% of that of the wild type alone. If the mutant T antigens were heated at 100°C prior to being added to the replication assay, no inhibition was observed (data not shown). Thus, 5030, 5031, and 5061 represent three different classes of replication-defective mutants. Mutant 5061 exhibits trans dominance both in vivo and in vitro, while 5031 is trans dominant in vitro but not 
DISCUSSION
The SV40-encoded large T antigen plays an essential role in several aspects of viral infection, including DNA replication, gene expression, and virion assembly. In addition to these roles in productive infection, T antigen is necessary and often sufficient to transform cells in culture and to induce tumors in test animals. The study of T antigen is complicated by the fact that it occurs in multiple differentially phosphorylated forms and oligomeric states, the functional significance of only some of which are understood. Nevertheless, genetic and biochemical experiments have revealed that T antigen possesses multiple biochemical activities, some of which are localized to discrete functional domains while others require cooperation among different domains. Understanding how these different activities interact, and how their cooperative action contributes to specific aspects of viral infection, is the current goal of several laboratories.
T antigen is an ATP binding protein, and the binding of this nucleotide results in dramatic changes in T antigen's biochemical properties and activities. First, T-antigen-catalyzed hydrolysis of ATP to ADP and inorganic phosphate (P i ) is essential for its role as a DNA helicase in viral DNA replication (50, 60) . Second, the binding of ATP results in an increased binding affinity of T antigen for site II DNA within the viral ori (4, 12) . Finally, ATP binding induces T-antigen hexamerization and the assembly of T-antigen double hexamers on ori-containing DNA (11, 34, 42) . Experiments with SV40 mutants or adenovirus-SV40 hybrids that express truncated T antigens, and with T antigen fragments generated by partial proteolysis, have mapped the ATPase domain to approximately amino acids 371 to 625 (2, 9-11, 18, 34, 42) . This is consistent with biochemical and computer modeling studies that localize the ATP binding site to amino acids 418 to 528 (7) . Interestingly, T-antigen sequences required for binding to the cellular tumor suppressor p53 are also located in this domain (26) .
We have been characterizing a collection of T-antigen mutants that carry amino acid substitutions, deletions, or insertions within the ATPase domain (19, 44, 54) . This study reports the initial characterization of three mutant T antigens that alter amino acids within the ATP binding pocket. All three mutants were previously shown to be defective for viral DNA replication in cell culture assays. However, while mutants 5030 and 5031 could be complemented by supplying a wild-type T antigen in trans, mutant 5061 is trans dominant negative. We hoped that by examining the properties of these purified mutant proteins we could determine the basis for their replication defects and gain some insights into the mechanisms involved in trans dominance.
Biochemical nature of the replication defects. All three mutant T antigens were defective in in vitro SV40 DNA replication assays. However, the biochemical basis for this defect seemed to differ in each case.
The 5061 T antigen had no measurable ATPase activity and thus was also found to be defective in DNA helicase and ori-specific unwinding assays. In addition, 5061 T antigen failed to hexamerize in response to ATP. This protein retained significant sequence-specific DNA binding activity, but its binding to site II DNA was not stimulated by ATP. These results indicate that 5061 T antigen is either defective for ATP binding or that it binds to ATP but is defective for both ATP hydrolysis and ATP-induced changes in conformation. The 5061 mutation results in a replacement of G(431) with three amino acids (A L E). This glycine is part of the GXXXXGK motif, which, in many nucleotide binding proteins, forms a loop that contacts the bound nucleotide (7, 56) . It is possible that these additional residues either sterically block ATP binding or that they indirectly affect binding by altering the conformation of the binding pocket. The inability of 5061 T antigen to bind ATP is consistent with its defects in DNA helicase, assembly of dodecamers on ori, and ori-specific unwinding, any of which could account for its replication defect. While 5061 is defective for multiple T-antigen activities, it is unlikely that the mutation leads to a global distortion of the entire protein. Purified 5061 T antigen exhibits efficient sequence-specific DNA binding activity and displays the normal distribution of oligomeric forms on nondenaturing gels. Furthermore, 5061 transforms cultured cells with the same efficiency as wild-type T antigen.
The 5030 mutation results in a single amino acid substitution of P417S. The purified T antigen exhibited measurable but significantly reduced ATPase and DNA helicase activities (10% of those of the wild type) and an even greater defect (Ͻ1% of that of the wild type) in ori-specific unwinding. The 5030 T antigen hexamerized in response to ATP, suggesting that the P417S substitution does not significantly affect ATP binding or any ATP-induced conformational changes necessary for its assembly into hexamers. Similarly, the 5030 mutation had little or no effect on sequence-specific binding to site I DNA. In contrast, binding to site II was altered. The 5030 T-antigen binding to site II was only 5 to 15% as efficient as was that of wild-type T antigen, and this binding was not stimulated by ATP. DNA band shift experiments showed that while 5030 T antigen assembled hexamers on ori-containing DNA relatively efficiently, assembly into dodecamers was much reduced. The formation of T-antigen dodecamers on ori DNA involves the cooperative binding of hexamers. Thus, one possibility is that the P417S change reduces the cooperativity between hexamers. Since both the assembly of T-antigen dodecamers on ori DNA and ATP hydrolysis are necessary for ori-specific unwinding, the reduced levels of these activities are probably responsible for the 5030 replication defect. The fact that these activities are greatly reduced, but not totally eliminated, is consistent with the observation that a very low but detectable (Ͻ5%) level of 5030 DNA replication is observed in both in vivo and in vitro assays.
The 5031 mutations result in three amino acid substitutions: D402N, V404M, and V413M. Since the mutant with the D402N change alone is replication positive and viable, the 5031 replication defect is probably due to one of the other two substitutions or to their combined effect. The purified 5031 T antigen exhibited a significant level of activity (20 to 40% of wild-type levels) in ATPase, DNA helicase, and ori-specific unwinding assays. Furthermore, it efficiently hexamerized in response to ATP and assembled into hexamers and dodecamers on ori-containing DNA about as well as the wild type. The 5031 T antigen bound to site I DNA with wild-type efficiency at both 4 and 37°C. Binding to site II DNA was somewhat temperature sensitive. At 4°C binding to site II was the same as that of the wild type, and this binding was stimulated by ATP. However, when assayed at 37°C, binding was reduced to 5 to 10% of wild-type levels, and binding did not increase in the presence of ATP. The 5031 T antigen efficiently assembles dodecamers on ori DNA and exhibits ori-specific unwinding activity at 37°C. Thus, the growth defect exhibited by 5031 may be due to (i) a defect in the stability of the DNA-T-antigen complex, (ii) a defect in some T-antigen function we have not tested, or (iii) the cumulative effect of the mutation on multiple T-antigen functions.
Effect of mutations on T-antigen interdomain communication. The SV40 T-antigen DNA binding and ATPase activities clearly reside in distinct functional domains. However, these domains must act cooperatively for proper T-antigen function. One manifestation of this interdomain communication is the increased affinity for ori-containing DNA exhibited by T antigen in the presence of ATP. We envision three possible models to explain the mechanism by which this communication is effected. In the first model, increased affinity for ori is achieved by virtue of the ATP-induced hexamerization of T antigen. In the second model, interdomain communication is effected through the direct physical association of the separate domains. Model three evokes an allosteric mechanism that involves no direct contacts between the domains.
The fact that mutant 5031 is competent for ATP-induced hexamerization and assembly on ori-containing DNA yet is defective for the ATP-induced increase in the affinity for ori argues against the first model. Additional experiments will be necessary to distinguish between models two and three.
trans-Dominant inhibition of viral DNA replication by mutant T antigens. Mutant 5061 is extremely trans dominant negative for DNA replication in vivo, while 5030 and 5031 are FIG. 10 . Effect of mutant T antigens on wild-type-stimulated in vitro replication. Various ratios of wild-type and mutant T antigens were assessed for their ability to stimulate SV40 DNA replication in vitro, as described in the legend to Fig. 2. VOL. 71, 1997 EFFECT OF ATP ON MUTANT T ANTIGENS 7557
on January 11, 2018 by guest http://jvi.asm.org/ not. We had hoped to exploit the crude in vitro DNA replication system to discern the biochemical basis for the 5061 dominant-negative phenotype. Unfortunately, the in vitro system we used does not reflect the in vivo dominant-negative phenotype of 5061 in two important respects: (i) 5061 T antigen is only marginally trans dominant in vitro, while in vivo it inhibits wild-type replication over 100-fold; (ii) while 5031 is not trans dominant in vivo, the purified 5031 T antigen exhibits the same degree of dominance in vitro as 5061. A similar level of dominant inhibition of wild-type DNA replication in vitro has been reported with other defective mutants that do not exhibit trans dominance in vivo (3) . The observation that the purified 5030 T antigen is not dominant negative in vitro indicates that this effect is specific to certain mutations. We are currently undertaking experiments using a more defined in vitro replication system to see if it more accurately reflects the in vivo case.
